PRECISION PHARMACOTHERAPY IN TYPE 2 DIABETES MELLITUS: EVALUATING THE CARDIO-RENAL AND GLYCEMIC EFFICACY OF TARGET-SPECIFIC PATHWAY MODULATION. Wor.Bul.Pub.Helt. [Internet]. 2026 Mar. 26 [cited 2026 Apr. 17];56:82-4. Available from: https://www.scholarexpress.net/index.php/wbph/article/view/5983